Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure

Eur Heart J. 2017 Jul 14;38(27):2095-2099. doi: 10.1093/eurheartj/ehw577.

Authors

Udo Bavendiek¹, Lukas Aguirre Davila², Armin Koch², Johann Bauersachs¹

Affiliations

¹ Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 01, 30625 Hannover, Germany.
² Department of Biostatistics, Hannover Medical School, Carl-Neuberg-Str. 01, 30625 Hannover, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / mortality
Cardiac Glycosides / therapeutic use
Clinical Trials as Topic
Digoxin / therapeutic use*
Drug Prescriptions / statistics & numerical data
Heart Failure / drug therapy*
Heart Failure / mortality
Humans
Publication Bias
Retrospective Studies
Risk Assessment
Selection Bias

Substances

Anti-Arrhythmia Agents
Cardiac Glycosides
Digoxin